{"entity":{"type":"insider","cik":"0001291219","url":"/insider/0001291219","json_url":"/insider/0001291219.json","name":"Kelley Kenneth J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":228,"n_filings":24,"first":"2007-03-16","last":"2021-04-14","span_basis":"filed_date"},"name_variants":[{"name":"Kelley Kenneth J","source":"filing","n_filings":24,"first_seen":"2007-03-16","last_seen":"2021-04-14"}],"transactions":[{"id":5356354,"accession":"0001179110-21-004416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-004416","line_url":"/filing/0001179110-21-004416#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":179833.0,"shares_owned_after_display":"179,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-14","filed_date":"2021-04-14","scope":"insider"},{"id":4360097,"accession":"0001179110-21-002487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-002487","line_url":"/filing/0001179110-21-002487","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.34348,"price_display":"45.34","price_state":"stated","total_value":226717.4,"total_display":"226,717.40","total_whole":"226,717","shares_owned_after":185333.0,"shares_owned_after_display":"185,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-01","scope":"insider","n_lines":2},{"id":5410391,"accession":"0001179110-21-001008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-001008","line_url":"/filing/0001179110-21-001008","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":48.11879048,"price_display":"48.12","price_state":"stated","total_value":240593.9524,"total_display":"240,593.95","total_whole":"240,594","shares_owned_after":190079.0,"shares_owned_after_display":"190,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-01","scope":"insider","n_lines":2},{"id":5379302,"accession":"0001179110-21-000059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-000059","line_url":"/filing/0001179110-21-000059","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":42.911116,"price_display":"42.91","price_state":"stated","total_value":214555.58,"total_display":"214,555.58","total_whole":"214,556","shares_owned_after":195123.0,"shares_owned_after_display":"195,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-04","scope":"insider","n_lines":2},{"id":3252659,"accession":"0001179110-20-011734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-011734","line_url":"/filing/0001179110-20-011734#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35086.0,"shares_display":"35,086","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":1438526.0,"total_display":"1,438,526.00","total_whole":"1,438,526","shares_owned_after":199833.0,"shares_owned_after_display":"199,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-07","scope":"insider"},{"id":2266032,"accession":"0001179110-20-011550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-011550","line_url":"/filing/0001179110-20-011550#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31792.0,"shares_display":"31,792","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":1303472.0,"total_display":"1,303,472.00","total_whole":"1,303,472","shares_owned_after":234919.0,"shares_owned_after_display":"234,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-02","scope":"insider"},{"id":3187079,"accession":"0001179110-20-011448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-011448","line_url":"/filing/0001179110-20-011448#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":41.25,"price_display":"41.25","price_state":"stated","total_value":412500.0,"total_display":"412,500.00","total_whole":"412,500","shares_owned_after":266711.0,"shares_owned_after_display":"266,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-27","filed_date":"2020-11-27","scope":"insider"},{"id":3187076,"accession":"0001179110-20-011448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-011448","line_url":"/filing/0001179110-20-011448#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9671.0,"shares_display":"9,671","price_per_share":41.5004,"price_display":"41.50","price_state":"stated","total_value":401350.3684,"total_display":"401,350.37","total_whole":"401,350","shares_owned_after":276711.0,"shares_owned_after_display":"276,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-25","filed_date":"2020-11-27","scope":"insider"},{"id":2484573,"accession":"0001179110-20-003999","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-003999","line_url":"/filing/0001179110-20-003999","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52629.0,"shares_display":"52,629","price_per_share":14.225933333333334,"price_display":"14.23","price_state":"stated","total_value":748696.6454,"total_display":"748,696.65","total_whole":"748,697","shares_owned_after":260010.0,"shares_owned_after_display":"260,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-19","scope":"insider","n_lines":3},{"id":8673829,"accession":"0001159036-15-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001159036-15-000071","line_url":"/filing/0001159036-15-000071#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":420000.0,"total_display":"420,000.00","total_whole":"420,000","shares_owned_after":198051.0,"shares_owned_after_display":"198,051","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-18","filed_date":"2015-06-22","scope":"insider"},{"id":8293267,"accession":"0001209191-15-024140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-024140","line_url":"/filing/0001209191-15-024140#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":15.3345,"price_display":"15.33","price_state":"stated","total_value":613380.0,"total_display":"613,380.00","total_whole":"613,380","shares_owned_after":194876.0,"shares_owned_after_display":"194,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-09","scope":"insider"},{"id":3145722,"accession":"0001483813-12-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001483813-12-000028","line_url":"/filing/0001483813-12-000028#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.6987,"price_display":"5.70","price_state":"stated","total_value":113974.0,"total_display":"113,974.00","total_whole":"113,974","shares_owned_after":150000.0,"shares_owned_after_display":"150,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-27","filed_date":"2012-08-28","scope":"insider"},{"id":2578467,"accession":"0001209191-12-028569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-028569","line_url":"/filing/0001209191-12-028569#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":7.49,"price_display":"7.49","price_state":"stated","total_value":149800.0,"total_display":"149,800.00","total_whole":"149,800","shares_owned_after":130000.0,"shares_owned_after_display":"130,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-14","filed_date":"2012-05-16","scope":"insider"},{"id":7601318,"accession":"0001181431-07-035729","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001181431-07-035729","line_url":"/filing/0001181431-07-035729","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22500.0,"shares_display":"22,500","price_per_share":10.264217777777779,"price_display":"10.26","price_state":"stated","total_value":230944.9,"total_display":"230,944.90","total_whole":"230,945","shares_owned_after":19200.0,"shares_owned_after_display":"19,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-25","filed_date":"2007-05-25","scope":"insider","n_lines":24},{"id":7257586,"accession":"0001181431-07-034474","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-07-034474","line_url":"/filing/0001181431-07-034474","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.552853333333333,"price_display":"10.55","price_state":"stated","total_value":158292.8,"total_display":"158,292.80","total_whole":"158,293","shares_owned_after":21200.0,"shares_owned_after_display":"21,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-18","filed_date":"2007-05-22","scope":"insider","n_lines":3},{"id":7969092,"accession":"0001181431-07-031023","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001181431-07-031023","line_url":"/filing/0001181431-07-031023#line-14","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HTI","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3076.0,"shares_display":"3,076","price_per_share":10.38,"price_display":"10.38","price_state":"stated","total_value":31928.88,"total_display":"31,928.88","total_whole":"31,929","shares_owned_after":23524.0,"shares_owned_after_display":"23,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-07","filed_date":"2007-05-09","scope":"insider"},{"id":7969088,"accession":"0001181431-07-031023","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001181431-07-031023","line_url":"/filing/0001181431-07-031023#line-13","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HTI","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":10.39,"price_display":"10.39","price_state":"stated","total_value":30131.0,"total_display":"30,131.00","total_whole":"30,131","shares_owned_after":20624.0,"shares_owned_after_display":"20,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-07","filed_date":"2007-05-09","scope":"insider"},{"id":7969085,"accession":"0001181431-07-031023","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001181431-07-031023","line_url":"/filing/0001181431-07-031023#line-12","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HTI","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.4,"price_display":"10.40","price_state":"stated","total_value":20800.0,"total_display":"20,800.00","total_whole":"20,800","shares_owned_after":18624.0,"shares_owned_after_display":"18,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-07","filed_date":"2007-05-09","scope":"insider"},{"id":7969082,"accession":"0001181431-07-031023","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001181431-07-031023","line_url":"/filing/0001181431-07-031023#line-11","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HTI","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":10.45,"price_display":"10.45","price_state":"stated","total_value":15675.0,"total_display":"15,675.00","total_whole":"15,675","shares_owned_after":15300.0,"shares_owned_after_display":"15,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-07","filed_date":"2007-05-09","scope":"insider"},{"id":7969077,"accession":"0001181431-07-031023","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-07-031023","line_url":"/filing/0001181431-07-031023#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HTI","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001291219","owner_name":"Kelley Kenneth J","owner_display_name":"Kelley Kenneth J","owner_url":"/insider/0001291219","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":10.42,"price_display":"10.42","price_state":"stated","total_value":9378.0,"total_display":"9,378.00","total_whole":"9,378","shares_owned_after":17500.0,"shares_owned_after_display":"17,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-07","filed_date":"2007-05-09","scope":"insider"}],"collapsed":true,"next_cursor":"2007-05-07|7969077","ledger_fault":false,"count":{"value":228,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":223,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":228},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001159036","name":"HALOZYME THERAPEUTICS, INC.","url":"/issuer/0001159036","role":"Director","n_filings":24,"first_seen":"2007-03-16","last_seen":"2021-04-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291219","retrieved_at":"2026-08-24T01:53:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}